Writing on the wall. Wait until the big money moves in on this. RAP is going back for a real shot for FDA approval.
The fact patients were administered medicine and then tested shows how bad the controls were first time round and we now have a world class institute managing this (Should have been done the first time)!!! \
Let alone the updated algorithms... !!
Giddyup RAP
Ann: ResApp Enrols First Patient in SMARTCOUGH-C-2 Study, page-11
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #